Diltiazem Hydrochloride Injection, Solution
Product Images NDC 25021-319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 25021-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dil0b 0000 01)

Structural Formula (Dil0b 0000 01)
Chemical structure of diltiazem hydrochloride, showing the arrangement of its aromatic rings, sulfur atom, and functional groups including methoxy and acetoxy substituents.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 02)

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 02)
Label for Diltiazem HCl Injection, 25 mg per 5 mL (5 mg/mL) single-dose vial. The label states it is for direct intravenous bolus injection and continuous intravenous infusion. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes bar code, lot and expiration date fields, and instructions to discard unused portion and remove from refrigeration before use.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 03)

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 03)
Label for Diltiazem Hydrochloride Injection, 50 mg per 10 mL (5 mg per mL) intravenous solution. The label indicates it is a sterile single-dose vial for direct intravenous bolus injection and continuous intravenous infusion. The product is manufactured for Sagent Pharmaceuticals by a facility in India. The label includes usage instructions, lot and expiration date fields, and barcode.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 04)

Package Label – Principal Display Panel – Vial Label (Dil0b 0000 04)
Label for Diltiazem Hydrochloride Injection, 125 mg per 25 mL (5 mg per mL), sterile solution for intravenous use. The single-dose vial label by Sagent Pharmaceuticals specifies 25 mL volume for direct intravenous bolus and continuous infusion. The label includes storage instructions and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.